CAPRICOR THERAPEUTICS

Capricor Therapeutics to Present Third Quarter 2024 Financial Results and Recent Corporate Update on November 13

05 نوفمبر 2024 09:00:00 بحسب Nasdaq GlobeNewswire

Capricor Therapeutics Announces Closing of Underwritten Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

18 أكتوبر 2024 16:01:00 بحسب Nasdaq GlobeNewswire

Capricor Therapeutics Announces Pricing of Approximately $75 Million Public Offering of Common Stock

17 أكتوبر 2024 06:00:00 بحسب Nasdaq GlobeNewswire

Capricor Therapeutics Announces Proposed Public Offering of Common Stock

16 أكتوبر 2024 16:17:48 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months High: CAPRICOR THERAPEUTICS INC. - COMMON STOCK

15 أكتوبر 2024 12:27:21 بحسب NetDania Notify

Capricor Therapeutics Announces Positive Long-Term Data from HOPE-2 OLE Study in Duchenne Muscular Dystrophy at 2024 World Muscle Society Congress

11 أكتوبر 2024 09:15:00 بحسب Nasdaq GlobeNewswire

Capricor Therapeutics Announces Initiation of Rolling Submission of Biologics License Application (BLA) with U.S. FDA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy

09 أكتوبر 2024 09:15:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months High: CAPRICOR THERAPEUTICS INC. - COMMON STOCK

04 أكتوبر 2024 09:47:23 بحسب NetDania Notify

Capricor Therapeutics to Present Long-Term Data from HOPE-2 Open Label Extension Study at 2024 World Muscle Society Congress

04 أكتوبر 2024 09:15:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months High: CAPRICOR THERAPEUTICS INC. - COMMON STOCK

01 أكتوبر 2024 09:48:05 بحسب NetDania Notify

NetDania - New 12 months High: CAPRICOR THERAPEUTICS INC. - COMMON STOCK

30 سبتمبر 2024 11:30:56 بحسب NetDania Notify

NetDania - New 12 months High: CAPRICOR THERAPEUTICS INC. - COMMON STOCK

25 سبتمبر 2024 09:45:14 بحسب NetDania Notify

NetDania - New 12 months High: CAPRICOR THERAPEUTICS INC. - COMMON STOCK

24 سبتمبر 2024 09:45:18 بحسب NetDania Notify

Capricor Therapeutics Announces Intent to File Biologics License Application for Full Approval of Deramiocel for the Treatment of Duchenne Muscular Dystrophy Cardiomyopathy

24 سبتمبر 2024 08:00:01 بحسب Nasdaq GlobeNewswire

Capricor Therapeutics to Provide Duchenne Muscular Dystrophy Program Update on September 24, 2024

23 سبتمبر 2024 09:25:00 بحسب Nasdaq GlobeNewswire

Capricor Therapeutics Signs Binding Term Sheet with Nippon Shinyaku for European Expansion and Commercialization of Deramiocel for the Treatment of Duchenne Muscular Dystrophy

17 سبتمبر 2024 09:15:00 بحسب Nasdaq GlobeNewswire

Capricor Therapeutics to Present at Upcoming Investor and Scientific Conferences

06 سبتمبر 2024 08:30:00 بحسب Nasdaq GlobeNewswire

Capricor Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update

07 أغسطس 2024 16:05:01 بحسب Nasdaq GlobeNewswire

Capricor Therapeutics to Present Second Quarter 2024 Financial Results and Recent Corporate Update on August 7

31 يوليو 2024 09:00:00 بحسب Nasdaq GlobeNewswire

Capricor Therapeutics Set to Join Russell 2000® and Russell 3000® Indexes

01 يوليو 2024 09:00:00 بحسب Nasdaq GlobeNewswire